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Summary
 
The transcription factor NF-
 
k
 
B is sequestered in the cytoplasm by the inhibitor proteins of the
I
 
k
 
B family. Each member of the I
 
k
 
B exhibits structural and biochemical similarities as well as
differences. In an effort to address the functional redundancy of two closely related I
 
k
 
B mole-
cules, I
 
k
 
B
 
a
 
 and I
 
k
 
B
 
b
 
, we generated knock-in mice by replacing the I
 
k
 
B
 
a
 
 gene with the I
 
k
 
B
 
b
 
gene. The knock-in mice do not express I
 
k
 
B
 
a
 
, but express a T7-tagged I
 
k
 
B
 
b
 
 under the pro-
moter and regulatory sequence of 
 
ikba.
 
 Unlike the I
 
k
 
B
 
a
 
-deficient mice, which display severe
postnatal developmental defects and die by postnatal day 8, homozygous knock-in mice survive
to adulthood, are fertile, and exhibit no apparent abnormalities. Furthermore, thymocytes and
embryonic fibroblasts from the knock-in animals exhibit an inducible NF-
 
k
 
B response similar
to that of wild-type animals. These results indicate that I
 
k
 
B
 
a
 
 and I
 
k
 
B
 
b
 
 share significant simi-
larities in their biochemical activity, and that they acquired their different functions from diver-
gent expression patterns during evolution.
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N
 
uclear factor 
 
k
 
B (NF-
 
k
 
B)
 
1
 
 plays an important role in
regulating genes involved in inflammatory and im-
mune responses. In vertebrates, NF-
 
k
 
B consists of homo-
or heterodimers of the subunits p50, p52, RelA, RelB, and
cRel. These subunits share a highly conserved NH
 
2
 
-termi-
nal sequence termed the Rel-homology domain (RHD),
which is required for DNA binding, dimerization, nuclear
localization, and interaction with the inhibitor I
 
k
 
B mole-
cules (for review see references 1–5). In resting cells, NF-
 
k
 
B is sequestered in the cytoplasm by the inhibitor I
 
k
 
Bs.
Cytoplasmic retention is achieved via interaction between
a conserved sequence motif known as the ankyrin repeats
in the I
 
k
 
Bs and the RHDs of NF-
 
k
 
B subunits. Upon cell
stimulation by a variety of agents, specific serine residues
on the I
 
k
 
Bs are phosphorylated, signaling for ubiquitina-
tion which in turn targets I
 
k
 
Bs for proteasome-mediated
degradation. NF-
 
k
 
B released from the inhibitor translo-
cates into the nucleus and activates transcription of target
genes, which include those involved in inflammatory, im-
mune, and acute phase responses.
In mammalian cells, the I
 
k
 
B family consists of I
 
k
 
B
 
a
 
,
I
 
k
 
B
 
b
 
, I
 
k
 
B
 
e
 
, Bcl-3, p105, and p100 (for review see refer-
ences 2–4). Knockout mice studies have revealed the criti-
cal roles that some of these I
 
k
 
B molecules play in develop-
ment and immune responses. For example, the knockout
mice of I
 
k
 
B
 
a
 
 have increased basal NF-
 
k
 
B activity in he-
matopoietic organs. Extensive granulopoeisis, dermatitis,
and death by postnatal day 8–10 are observed in these mu-
tant animals (5, 6). In contrast, p100-deficient mice dis-
played gastric hyperplasia and an impaired proliferative re-
sponse in lymphocytes (7). Bcl-3–deficient mice develop
normally but are incapable of antigen-specific antibody re-
sponse (8, 9). These differences in phenotypes suggest that
each I
 
k
 
B family member plays a unique and nonredundant
role in regulating NF-
 
k
 
B activity in the hematopoietic system.
Among the I
 
k
 
B members, I
 
k
 
B
 
a
 
 and I
 
k
 
B
 
b
 
 are the most
prominent and have been extensively characterized. I
 
k
 
B
 
a
 
and I
 
k
 
B
 
b
 
 were first identified as two fractions from HeLa
extracts that had similar kinetics of activities (10). In addi-
tion to the ankyrin motif, I
 
k
 
B
 
a
 
 and I
 
k
 
B
 
b
 
 also have similar
phosphoacceptor sites in their NH
 
2
 
 termini that mediate
signal-induced degradation and a similar specificity of in-
 
1
 
Abbreviations used in this paper:
 
 EMSA, electrophoretic mobility shift assay;
ES, embryonic stem; MEF, mouse embryo fibroblast, NF-
 
k
 
B, nuclear
factor 
 
k
 
B.
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I
 
k
 
B
 
b
 
 Substitutes for I
 
k
 
B
 
a
 
 In Vivo
 
teraction with the RelA and cRel complexes (11, 12).
Given these similarities, it seemed surprising that I
 
k
 
B
 
b
 
could not compensate for I
 
k
 
B
 
a
 
 in the I
 
k
 
B
 
a
 
-deficient
mice. Two potential explanations are: first, in spite of the
similarities in structure, these two proteins have different in
vivo biochemical activities and, therefore, they cannot re-
place each other’s function. Alternatively, they are in vivo
biochemically equivalent, but differential expression pat-
terns have made them functionally incapable of compensat-
ing for one another. In an attempt to discriminate between
these two possibilities, we have replaced I
 
k
 
B
 
a
 
 with I
 
k
 
B
 
b
 
using homologous recombination in embryonic stem cells
in order to determine whether I
 
k
 
B
 
a
 
 can be functionally
replaced by I
 
k
 
B
 
b
 
. The targeting event brought the inte-
grated I
 
k
 
B
 
b
 
 gene under the control of the 
 
ikba promoter
and at the same time introduced a null mutation in ikba.
Here we report that the “knock-in” mice develop to adult-
hood without apparent abnormalities, are fertile, have no in-
crease in their basal NF-kB activity, and can elicit NF-kB
responses. These observations contrast strongly with those
obtained with the IkBa-deficient mice, which present ex-
tensive granulopoeisis, dermatitis, and death by postnatal day
8–10 (5, 6). Thus, our data demonstrate that in vivo IkBa
can be functionally replaced by IkBb, and that these two
molecules have acquired different functions by differential
tissue pattern expressions and responses to NF-kB inducers.
Materials and Methods
Generation of the IkBa Knock-in Mice. To generate mice with
the replacement of IkBa by IkBb, the targeting vector pPNT-
abki was constructed using the pPNT vector (13). Murine ikba
and ikbb genomic clones were used for vector construction. A 59
4.7-kb NotI–SalI and a 39 9.5-kb HindIII–NotI restriction frag-
ment of ikba genomic sequence were cloned into the respective
sides of the neo cassette in the pPNT targeting vector. A pair of
oligonucleotide linkers containing the bacterial phage T7 Tag, and
a 9.5-kb NcoI–SalI genomic restriction fragment containing the
entire coding sequence of ikbb, were inserted downstream of the
translation initiation of ikba. To ensure efficient translation initia-
tion from the T7 Tag sequence, the endogenous translational ini-
tiation sequence of ikbb was deleted. Additionally, to ensure that
the presence of the pgk-neo cassette would not interfere with tran-
scription of the recombined ikbb, loxp sites were inserted flanking
the 59 and 39 ends of the pgk-neo cassette to allow cyclic AMP re-
sponsive element–mediated excision of this marker. Since our
studies (see below) indicated that transcription of the knock-in
allele was not affected, the pgk-neo cassette was not removed subse-
quently. The resulting vector pPNT-abki was linearized by NotI
and electroporated into murine CJ7 embryonic stem (ES) cells.
Neomycin- and gancyclovir-resistant cells were selected and
screened by Southern blot analysis using a 39 external probe of the
ikba gene. DNA from a homologously recombined locus yields an
11-kb EcoRV fragment, whereas the wild-type DNA yields a
15-kb fragment. In addition, hybridization using several internal
probes, including neomycin, confirmed that the entire genomic
region of the IkBb gene was integrated into the IkBa locus. Cor-
rectly targeted ES cells were injected into blastocysts or aggregated
with morula of ICR mice. Male chimeras were mated with ICR
females to obtain germline transmission of the mutated allele.
Western Blot Analysis, Electrophoretic Mobility Shift Assay, and
Immunoprecipitation. Single cell suspensions of thymocytes or sple-
nocytes were prepared from 4–6-wk-old mice according to standard
procedures (14) in RPMI 1640 containing 10% heat-inactivated
FCS. Cells were incubated with 20 ng/ml of PMA and 1 mg/ml of
PHA, or 5 ng/ml mouse TNF at 378C for the indicated periods of
time before harvest. Preparation of cytoplasmic and nuclear extracts
was performed as previously described (15). For immunoprecipita-
tion, a total of 5 3 105 ES cells or 6 3 106 thymocytes were
incubated with 0.5 mCi/ml of [35S]methionine in methionine-free
DMEM containing 10% dialyzed FCS for 8 h at 378C. Cells were
lyzed in radioimmunoprecipitation assay buffer and immunoprecip-
itation was performed as previously described (16). Western blot
analysis using equal amounts of cytoplasmic extracts was carried out
using standard protocols. For electrophoretic mobility shift assay
(EMSA), nuclear extracts were tested for binding to the palindromic
kB-specific probe (17) or an octamer-specific probe (18).
Histology and Flow Cytometry Analysis. Mouse tissues were im-
mersion fixed in 10% buffered formalin and embedded in paraffin
blocks. Sections were stained with hematoxylin and eosin. Flow
cytometry analysis with single cell suspension from thymus, spleen,
and bone marrow was performed using commercially available an-
tibodies with a flow cytometer (Becton Dickinson, San Jose, CA).
3 3 105 cells were first incubated with 1 mg of the antibodies and
then incubated with PE- or FITC-conjugated antibodies.
Results
IkBa Knock-in Mice. The murine IkBa gene was re-
placed by the IkBb gene in ES cells by homologous recom-
bination with the gene-targeting vector pPNT-abki (Fig. 1
A). The targeting vector deleted the entire coding sequence
of the IkBa gene and replaced it with the genomic se-
quence encoding the murine IkBb gene. To distinguish the
IkBb introduced by homologous recombination from the
endogenous IkBb, a 34-bp nucleotide sequence encoding
the bacterial phage T7-Tag was placed in front of the ATG
start codon of the IkBb gene in the targeting vector. This
targeting vector was transfected into CJ7 ES cells, and ES
cell clones carrying the replacement of the endogenous
IkBa gene were identified by Southern blot analysis (Fig. 1
B). The resulting knock-in allele was abbreviated as 1/ki or
ki/ki for heterozygotes or homozygotes, respectively.
To ensure that the homologous recombination resulted
in replacement of the IkBa gene with a functional IkBb
gene, an immunoprecipitation experiment was performed
in the ES cells. Extracts from [35S]methionine labeled wild-
type (1/1) and recombined (1/ki) ES cells were immu-
noprecipitated with antiserum against IkBb (Fig. 1 C, lanes
1 and 2), and then with antiserum against the T7-Tag
epitope (Fig. 1 C, lanes 3 and 4). The T7-Tag antiserum
precipitated a protein that is similar in molecular weight to
the IkBb protein in the recombinant ES cells but not in the
wild-type cells, indicating that the introduced IkBb was
expressed and can be distinguished from the endogenous
IkBb using antibodies against the T7-Tag epitope.
The Knock-in Animals Develop Normally and Present no
Changes in NF-kB Activity. Aggregation chimeras giving
germline transmission were obtained from two targeted ES1057 Cheng et al.
cell lines. Both lines of heterozygous animals (1/ki) were
crossed to obtain homozygous mice (ki/ki). Homozygous
ki/ki mice were born in normal Mendelian ratio, indicat-
ing that replacement of IkBa with IkBb did not affect em-
bryonic development (Fig. 1 D).
In contrast to the previously described IkBa-deficient
mice, which have severe developmental defects and die by
postnatal day 8 (5, 6), both lines of the ki/ki mice devel-
oped to adulthood. Examination of 5-wk-old ki/ki mice
revealed that the phenotype was both grossly and histologi-
cally similar to that of wild-type mice. Additionally, pe-
ripheral blood cells and serum biochemical analysis were
also similar to those from wild-type animals. In particular,
there was no evidence of granulopoiesis or epidermal dys-
plasia with hyperkeratosis as reported in the IkBa-deficient
mice (data not shown). The lack of granulopoiesis was fur-
ther confirmed by flow cytometric analysis of bone marrow
from wild-type and knock-in animals using the granulo-
cyte/macrophage-specific surface markers Mac-1 and Gr-1.
Additionally, a normal distribution of B and T lymphocyte
markers (CD4, CD8, TCRab, Thy1.2, CD25, B220, and
IgM) and erythroid marker (Ter119) was observed, indicat-
ing that the lymphoid and erythroid compartments of these
animals are also normal (data not shown).
To determine if replacement of IkBa by IkBb affected the
overall patterns of IkB and NF-kB gene expression, Western
blot analysis was performed. Splenocytes from wild-type
(1/1), heterozygous (1/ki), and homozygous (ki/ki) ani-
mals were analyzed. No differences in the steady-state levels
of p105, p100, p50, and RelA were found between wild-type
and knock-in splenocyte extracts (Fig. 2 A). As expected,
IkBa protein was absent in the homozygous ki/ki animals,
whereas the T7-Tag antibody detected a protein that mi-
grated to the identical position as the IkBb protein in 1/ki
Figure 1. Targeted replacement of IkBa with the IkBb gene. (A) The
targeting vector pPNT-abki is shown at the top. Black boxes and thick-
ened lines represent IkBb exons and introns. Open boxes and thin lines
represent IkBa exons and introns. Homologous recombination takes
place between the 59 and 39 flanking regions of the ikba gene, resulting in
replacement of the entire IkBa locus by IkBb. Additionally, the ATG
start codon of the IkBb was also replaced with the T7-Tag sequence. N,
NotI; Nc, NcoI; H, HindIII; E, EcoRV. (B) Southern blot analysis of
DNA isolated from ES cell lines. EcoRV-digested DNA from cells that
have undergone homologous recombination yielded an 11-kb signal
when hybridized to an external probe. (C) Immunoprecipitation analysis
of recombinant knock-in ES cells. Equal numbers of wild-type and 1/ki
ES cells were labeled with [35S]methionine and immunoprecipitated with
antiserum against IkBb (lanes 1 and 2) or T7-Tag (lanes 3 and 4). (D)
Analysis of homozygous mouse tail DNA. (Left) Southern blot analysis of
wild-type, heterozygous, and homozygous mouse tail DNA; (right) PCR
analysis of tail DNA using IkBa primers and neomycin primers. Amplifi-
cation of IkBa yields a 490-bp PCR product, whereas amplification of
the neomycin gene yields a 239-bp PCR product.
Figure 2. Expression of NF-kB/IkB proteins and NF-kB binding ac-
tivity in the knock-in mice. (A) Western blot analysis of splenocytes from
wild-type, heterozygous, and homozygous mice with antisera against
members of the NF-kB and IkB family. (B) Immunoprecipitation of
cRel- and RelA-associated IkB proteins. Homozygous (ki/ki) and wild-
type (1/1) thymocytes were labeled with [35S]methionine and immuno-
precipitated with RelA and cRel antiserum in nondenaturing conditions.
The immunoprecipitates were then denatured and sequentially reprecipi-
tated with IkBa, T7-Tag, and IkBb antisera. (C) EMSA for basal NF-kB
activity in thymus, spleen, brain, and MEFs of the knock-in mice. Whole
cell extracts were incubated with a palindromic kB-specific probe.1058 IkBb Substitutes for IkBa In Vivo
and ki/ki splenocyte extracts. Consistent with the presence of
extra IkBb molecules in the heterozygous and homozygous
animals, an increase was observed in the level of IkBb protein
in these animals compared with wild-type animals.
To demonstrate that the introduced IkBb could complex
with NF-kB subunits, coimmunoprecipitations were per-
formed (Fig. 2 B). Wild-type and knock-in thymocytes were
labeled with [35S]methionine and immunoprecipitated with
antiserum against RelA and cRel under native conditions.
The immunoprecipitates were denatured and then sequen-
tially immunoprecipitated with IkBa, T7-Tag, and IkBb
antiserum. Fig. 2 B shows that in wild-type cells a large
amount of IkBa was associated with RelA and/or cRel,
whereas only a small amount of IkBb was associated with
these subunits. On the other hand, in homozygous knock-in
cells, a large amount of T7-Tag-IkBb was associated with
RelA and/or cRel. The amount of T7-Tag–IkBb in homo-
zygous cells was comparable to that of IkBa in wild-type
cells. This indicates that the IkBb molecule introduced by
homologous recombination was expressed at a similar level
to IkBa in the wild-type animals, and that the introduced
IkBb is capable of interacting with the NF-kB subunits.
In IkBa-deficient animals, a prominent increase in the
basal level of NF-kB activity was observed in spleen and
thymus, emphasizing the importance of IkBa in control-
ling the basal NF-kB activity in hematopoietic organs (5, 6,
18). Thus, we determined the basal levels of NF-kB activ-
ity in thymus, spleen, brain, and embryonic fibroblasts from
control and mutant mice using EMSA. Basal NF-kB activ-
ity in ki/ki animals remained relatively similar to that in the
wild-type animals in all cell types examined (Fig. 2 C), in-
dicating that the introduced IkBb has replaced the role of
IkBa in controlling basal levels of NF-kB activity. Further-
more, NF-kB activity in nonhematopoietic cells was not
significantly altered, indicating that the presence of extra
IkBb molecules did not affect the basal machinery control-
ling NF-kB in these cells.
Signal-dependent NF-kB Response in the Thymus. A sig-
nificant feature that distinguishes IkBa and IkBb is the in-
ducibility of IkBa expression by NF-kB. After stimulation
with NF-kB inducers, NF-kB accumulates in the nucleus
and stimulates ikba transcription. Transcriptional stimula-
tion of the IkBa gene is mediated by several kB enhancer
elements present in its 59 flanking region (19, 20) and leads
to rapid accumulation of IkBa molecules, which in turn
inhibit NF-kB response. It has been proposed that this reg-
ulatory loop is responsible for the transient induction of
NF-kB activity. In contrast, the 59 upstream region of the
IkBb gene does not contain functional kB enhancers, and
its transcription is not regulated by NF-kB (11). This fun-
damental difference in regulation might be part of the func-
tional differences that exist between IkBa and IkBb. Since
the IkBb gene introduced by homologous recombination
was placed under the control of the ikba promoter, it
should become inducible by NF-kB. To test this inducibil-
ity and assess the functional consequence of this induction,
we stimulated thymocytes from wild-type and ki/ki ani-
mals with PMA and PHA and analyzed NF-kB activity by
EMSA (Fig. 3 A). Similar to the wild-type thymocytes, ki/ki
thymocytes exhibited a rapid increase in NF-kB activity 15
min after PMA/PHA stimulation. The increase persisted
for 6 h in wild-type and ki/ki cells, indicating that the
knock-in thymocytes were capable of eliciting signal-
dependent NF-kB response. Western blot analysis revealed
that, similar to IkBa in the wild-type, the T7-Tag–IkBb in
ki/ki thymocytes reaccumulated 60 min after stimulation.
The time course of reappearance for T7-Tag–IkBb is similar
to that for IkBa in the wild-type, indicating that the IkBb
gene placed downstream of the IkBa promoter is inducible
by NF-kB (Fig. 3 B). However, in spite of the increased
level of IkBb protein in basal condition and after induction,
signal-dependent NF-kB response in the knock-in thymo-
cytes remained relatively similar to the wild-type.
Signal-dependent NF-kB Response in Mouse Embryo Fibro-
blasts. A tissue-specific difference in function has been
proposed between IkBa and IkBb. Based on the relative
abundance of these two proteins, and on the fact that dis-
ruption of IkBa specifically affected NF-kB activity in he-
matopoietic cells, it has been postulated that IkBa plays a
more important role in hematopoietic cells, whereas IkBb
is more important in nonhematopoietic cells (18). To assess
the functional consequence of the replacement in nonhe-
matopoietic cells, we tested NF-kB response in fibroblasts
Figure 3. Signal dependent NF-kB activation in ki/ki thymocytes. (A)
NF-kB binding activity from wild-type (1/1) and ki/ki thymocytes
stimulated with PMA/PHA. Cells were stimulated for the indicated peri-
ods of time and EMSA was performed using the palindromic kB sequence
with 5 mg of nuclear extracts. Oct-1 binding activity was used as control.
(B) Western blot analysis of 1/1 and ki/ki thymocytes stimulated with
PMA/PHA. Similar to IkBa, T7-Tag–IkBb is induced and reaccumu-
lates after NF-kB stimulation. 20 mg of cytoplasmic extracts were used
per lane and a sister blot was probed with antilactic dehydrogenase (LDH)
antibodies as control for loading.1059 Cheng et al.
from 15-d-old embryos (Fig. 4). Wild-type and ki/ki pri-
mary mouse embryo fibroblasts (MEFs) were treated with
TNF-a for various periods of time and harvested for
EMSA and Western blot analysis. After 30 min of TNF-a
treatment, NF-kB was activated in both ki/ki and wild-
type MEFs (Fig. 4 A). The level of NF-kB induction was
similar, indicating that the knock-in fibroblasts are capable
of eliciting a normal NF-kB response. However, NF-kB
activity in ki/ki cells diminished to near basal level 3 h after
stimulation, whereas NF-kB activity in the wild-type re-
mained prominent at the same time point. A Western blot
analysis showed that the T7-Tag–IkBb in ki/ki cells was
induced after TNF-a stimulation, resulting in accumula-
tion of a significantly higher amount of IkBb in the knock-
in cells than in the wild-type cells (Fig. 4 B). The time at
which the T7-Tag–IkBb accumulates dramatically in the
cell correlates to the time point at which NF-kB activity
becomes noticeably lower in the ki/ki fibroblasts.
IkBb Is Capable of Postinduction Repression. Studies us-
ing primary fibroblasts from IkBa-deficient embryos have
demonstrated the importance of IkBa in postinduction re-
pression. NF-kB activity in fibroblasts lacking IkBa per-
sisted for .2 h after TNF-a removal, whereas NF-kB ac-
tivity in wild-type fibroblasts quickly returned to basal level
(within 30 min after stimulation; references 5, 6). To deter-
mine if the IkBb introduced by homologous recombina-
tion was capable of inhibiting the NF-kB activity after in-
duction, we performed postinduction experiments using
the ki/ki fibroblasts (Fig. 5). Wild-type and ki/ki primary
embryo fibroblasts were treated for 30 min with TNF-a,
after which TNF-a was removed, and the cells were har-
vested 60, 120, and 240 min later. In the wild-type MEFs,
NF-kB activity returned to basal levels nearly 60 min after
TNF-a removal (Fig. 5 A). In ki/ki MEFs, the return of
NF-kB to basal levels occurs on or after 120 min. A West-
ern blot analysis revealed that, similar to IkBa, the T7-
Tag–IkBb was upregulated after induction. However, the
time at which maximal T7-Tag–IkBb accumulated was
delayed compared to IkBa (60 min versus 2 h; Fig. 5 B).
Peak T7-Tag–IkBb accumulation corresponded to the
time at which NF-kB activity diminished to basal level.
Therefore, in the context of the IkBa promoter, IkBb can
be induced by NF-kB and is competent in postinduction
repression, although the time course of repression is slower
than that of IkBa in the wild-type cells.
Discussion
Using the knock-in approach, we have generated mice
that carry a replaced IkBa gene. A T7-Tag–modified IkBb
gene was expressed under the promoter and the 59 regula-
tory sequence of the IkBa gene. As a result, the ikba allele
was inactivated, and the introduced ikbb was expressed and
regulated like ikba. This approach allowed us to investigate
the functional similarity of IkBa and IkBb under physio-
logical conditions. The knock-in mice survived to adult-
hood and did not display any of the abnormalities that are
present in the IkBa-deficient mice. Basal levels of NF-kB
activity in the hematopoietic organs of the knock-in mice
were not elevated like those in the IkBa-deficient mice.
Furthermore, signal-induced NF-kB response in thy-
mocytes was also normal. These results indicate that IkBb
can functionally compensate for the absence of IkBa.
The notion that IkBa and IkBb are biochemically
equivalent is unexpected. Although many similarities exist
between these two molecules, significant biochemical dif-
ferences have also been reported. For example, IkBa deg-
radation is induced by a wide variety of NF-kB inducers,
Figure 4. Signal dependent NF-kB activation in ki/ki embryo fibro-
blasts. (A) NF-kB binding activty of wild-type (1/1) and ki/ki fibro-
blasts stimulated with TNF-a for the indicated periods of time. EMSA
was performed using 5 mg of nuclear extracts. Oct-1 binding was used in
parallel as control. (B) Western blot analysis of 1/1 and ki/ki fibroblasts
stimulated with TNF-a. The T7-Tag–IkBb reaccumulates in ki/ki fibro-
blasts after TNF-a stimulation. IkBa, T7-Tag–IkBb, and IkBb levels
were determined on blots with 20 mg of cytoplasmic extracts.
Figure 5. Postinduction repression of NF-kB in ki/ki embryo fibro-
blasts. (A) bF-kB binding activity of wild-type (1/1) and ki/ki fibro-
blasts treated with TNF-a for 30 min, after which cells were washed and
medium without TNF-a was added to the cells for the indicated period.
Nuclear extracts were prepared at the indicated periods after removal of
TNF-a. A loading control using the Oct-1 probe was also performed. (B)
Western blot analysis of 1/1 and ki/ki fibroblasts treated with TNF-a.
20 mg each of the total cell extracts were analyzed for levels of IkBa, T7-
Tag–IkBb, and the endogenous IkBb proteins.1060 IkBb Substitutes for IkBa In Vivo
but only a subset of these inducers effects IkBb degradation
(11, 21). The kinetics of degradation is also different be-
tween the two molecules. In general, IkBa has a more
rapid degradation than IkBb. Differences in the basal phos-
phorylation state, degradation mechanism (21), and affinity
to RelA (22) have also been shown for these two mole-
cules. These observations formed the basis of hypotheses
that the biochemical differences of IkBa and IkBb con-
tribute to functional differences for these two molecules.
One prominent functional difference that has been pro-
posed for the IkBs is the unique “chaperone” role of IkBb
(23). IkBb molecules resynthesized after stimulation have
been found to be hypophosphorylated. The hypophosphor-
ylated IkBb molecules can bind to NF-kB complexes, but
do not mask the nuclear localization signals of NF-kB.
Thus, they serve as chaperones for NF-kB complexes, pro-
tecting them from inhibition by the resynthesized IkBa
molecules and, therefore, maintaining the persistent activa-
tion of NF-kB. However, recent reports have provided ev-
idence against this model. For example, Miyamoto et al.
have reported that inhibition of IkBb degradation by pro-
teasome inhibitors does not have any effect on the consti-
tutive activity of NF-kB in WEHI cells (21). Prolonged
nuclear localization of NF-kB complexes also is not neces-
sarily associated with long-term depletion of IkBb (24).
Moreover, mice deficient in IkBb have been also gener-
ated (Attar, R.M., manuscript in preparation). NF-kB re-
sponses elicited by various extracellular stimuli, along with
various immune responses in these mice, are indistinguish-
able from those in wild-type mice, suggesting that persis-
tent NF-kB activation can take place in the absence of
IkBb. Furthermore, NF-kB activity in thymocytes re-
mained relatively unchanged in the knock-in mice, indi-
cating that the resynthesized IkBbs did not chaperone
more NF-kB complexes into the nucleus, although a large
excess of T7-Tag–IkBb is produced after stimulation (Fig.
3). It is surprising that such a large amount of IkBb did not
affect NF-kB activity. It appears as if the NF-kB com-
plexes in the knock-in cells are protected from the resyn-
thesized T7-Tag–IkBb just as the NF-kB complexes in the
wild-type cells are protected from the resynthesized IkBa.
Possibly, a separate mechanism exists that is independent of
the phosphorylation status of IkBb for maintaining the per-
sistent activation of NF-kB.
In light of the fact that the mice lacking IkBa but ex-
pressing IkBb controlled by the ikba promoter regulatory
elements appear healthy, we conclude that the two IkB
molecules are biochemically equivalent, and that certain
biochemical features reported on IkBb, such as hypophos-
phorylation or slow degradation, do not contribute signifi-
cantly to the functional difference between them. We pos-
tulate that the difference in relative level of expression
between these two molecules is a primary component of
their functional difference. It has been reported that these
two IkB molecules are expressed differently in different tis-
sues: IkBa mRNA is highly abundant in the spleen,
whereas IkBb mRNA is mostly abundant in the testis (11).
IkBa protein expression is also known to be higher in the
hematopoietic organs, whereas IkBb protein is distributed
equally between the hematopoietic and nonhematopoietic
tissues (5). Consistent with these observations, we are able
to immunoprecipitate a much larger amount of IkBa than
IkBb molecules in our thymocyte preparation (Fig. 2 B
and data not shown). Additionally, our Western blots also
show that the IkBb introduced by homologous recombi-
nation is expressed at a higher level than the endogenous
IkBb molecules in thymocytes (Fig. 3 B). On the other
hand, the relative increase in IkBb level does not appear to
be as high in the knock-in fibroblasts (Fig. 4 B). Although
we can not rule out that the differences in stability may
have contributed to some of the difference in steady state
expression level, our observations suggest that the ikba pro-
moter is more active in the hematopoietic system com-
pared with nonhematopoietic systems.
In addition to tissue-specific differences in expression,
the autoregulatory feature is also a fundamental difference
between the two molecules. It has been proposed that
NF-kB–inducible regulation of IkBa gene transcription is
important for terminating NF-kB response in nonhemato-
poietic cells. By performing a postinduction repression ex-
periment similar to that performed in the study of IkBa-
deficient mice, we found that the T7-Tag–IkBb molecule
can serve as an inhibitor similar to IkBa in postinduction
repression. This again supports the notion that IkBa and
IkBb are biochemically equivalent, and that regulatory kB
enhancer elements upstream of the genes are crucial com-
ponents of the functional differences between these IkBs. A
more recently identified member of the IkB family, IkBe,
also has this autoregulatory feature (25, 26). The fact that
some, but not all, members of the IkB family share this
property further implicates the importance of specific regu-
latory sequences in conferring different functions of these
molecules. This auto-regulatory feature appears to be closely
linked to tissue-specific difference in expression, as resyn-
thesis of excess T7-Tag–IkBb is associated with a different
effect in fibroblasts than in thymocytes.
Despite the increase in understanding NF-kB function,
the specificity and physiological relevance of the different
Rel/NF-kB and IkB proteins remains unclear. The knock-
outs and transgenic animals have provided important infor-
mation on the physiological roles of the individual mem-
bers (7, 27–35), but functional redundancy probably has
masked the full importance of each member. Besides
knowledge provided from single and double knockout
studies, the knock-in approach provides a powerful tool for
analysis of redundancy and the physiological function of in-
dividual members. The knock-in approach could be used
to dissect the importance of specific domains or structures
within a molecule in conferring specificity. Similar to this
study, the knock-in approach has been used to reveal re-
dundancy of two other transcription factor families, the
Engrailed family (En-1 and En-2; reference 36), and the
MyoD family (Myogenin and Myf-5; reference 37). In
both cases, replacement of a similar member of the same
family resulted in complete rescue of the phenotype from
single knockout. Together, these data demonstrate that1061 Cheng et al.
many closely related members of a gene family acquire dif-
ferent functions in evolution through divergence of gene
expression, rather than through divergence in biochemical
function. Because overlapping gene function is likely to be
prevalent in mammals, such approaches are critical for clar-
ifying the unique and overlapping function of members of
a family, and for determining the complete repertoire of
functions of individual genes.
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